380 related articles for article (PubMed ID: 10947953)
1. A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signalling pathway.
Ohta S; Takeuchi M; Deguchi M; Tsuji T; Gahara Y; Nagata K
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):395-404. PubMed ID: 10947953
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.
Sánchez-Elsner T; Botella LM; Velasco B; Corbí A; Attisano L; Bernabéu C
J Biol Chem; 2001 Oct; 276(42):38527-35. PubMed ID: 11486006
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
[TBL] [Abstract][Full Text] [Related]
4. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
7. Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.
Song CZ; Siok TE; Gelehrter TD
J Biol Chem; 1998 Nov; 273(45):29287-90. PubMed ID: 9792626
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling.
Qiao B; Padilla SR; Benya PD
J Biol Chem; 2005 Apr; 280(17):17562-71. PubMed ID: 15743758
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene.
Hua X; Liu X; Ansari DO; Lodish HF
Genes Dev; 1998 Oct; 12(19):3084-95. PubMed ID: 9765209
[TBL] [Abstract][Full Text] [Related]
10. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
11. Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling.
Rodriguez C; Huang LJ; Son JK; McKee A; Xiao Z; Lodish HF
J Biol Chem; 2001 Aug; 276(32):30224-30. PubMed ID: 11387330
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads.
Burton T; Liang B; Dibrov A; Amara F
Biochem Biophys Res Commun; 2002 Jul; 295(3):713-23. PubMed ID: 12099698
[TBL] [Abstract][Full Text] [Related]
14. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
Costamagna E; García B; Santisteban P
J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Song K; Cornelius SC; Reiss M; Danielpour D
J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
17. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
19. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins.
Hua X; Miller ZA; Wu G; Shi Y; Lodish HF
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13130-5. PubMed ID: 10557285
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of tristetraprolin by transforming growth factor-beta in human T cells.
Ogawa K; Chen F; Kim YJ; Chen Y
J Biol Chem; 2003 Aug; 278(32):30373-81. PubMed ID: 12754205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
